D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 75 Citations 21,679 622 World Ranking 14460 National Ranking 7465

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Surgery

Paul L. Nguyen mainly focuses on Prostate cancer, Internal medicine, Cancer, Surgery and Oncology. His Prostate cancer study integrates concerns from other disciplines, such as Prostate, Radiation therapy and Hazard ratio. His studies in Internal medicine integrate themes in fields like Gynecology and MEDLINE.

Paul L. Nguyen has included themes like Odds ratio, Body mass index, Logistic regression, Fatty acid synthase and Disease in his Cancer study. His study in Surgery is interdisciplinary in nature, drawing from both Nephrectomy and Risk factor. His studies deal with areas such as Incidence and Heart failure as well as Oncology.

His most cited work include:

  • Breast Cancer Subtype Approximated by Estrogen Receptor, Progesterone Receptor, and HER-2 Is Associated With Local and Distant Recurrence After Breast-Conserving Therapy (661 citations)
  • Marital Status and Survival in Patients With Cancer (511 citations)
  • Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis (344 citations)

What are the main themes of his work throughout his whole career to date?

Prostate cancer, Internal medicine, Oncology, Cancer and Radiation therapy are his primary areas of study. His Prostate cancer research is multidisciplinary, relying on both Prostate, Brachytherapy and Hazard ratio. Paul L. Nguyen combines subjects such as Interquartile range and Proportional hazards model with his study of Hazard ratio.

The concepts of his Internal medicine study are interwoven with issues in Gynecology and Surgery. Paul L. Nguyen has researched Oncology in several fields, including Clinical trial, Randomized controlled trial, Retrospective cohort study, Cohort and Comorbidity. His work deals with themes such as Odds ratio and Logistic regression, which intersect with Cancer.

He most often published in these fields:

  • Prostate cancer (78.69%)
  • Internal medicine (71.08%)
  • Oncology (52.66%)

What were the highlights of his more recent work (between 2018-2021)?

  • Prostate cancer (78.69%)
  • Internal medicine (71.08%)
  • Oncology (52.66%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Prostate cancer, Internal medicine, Oncology, Cancer and Radiation therapy. The Prostate cancer study combines topics in areas such as Prostate, Brachytherapy and Hazard ratio. The various areas that Paul L. Nguyen examines in his Hazard ratio study include Prostate-specific antigen and Urology.

His study in Internal medicine concentrates on Disease, Randomized controlled trial, Epidemiology, Confidence interval and Clinical trial. His study looks at the relationship between Oncology and fields such as MEDLINE, as well as how they intersect with chemical problems. His Prostatectomy research incorporates themes from Salvage therapy and Cohort.

Between 2018 and 2021, his most popular works were:

  • Association of Black Race with Prostate Cancer-Specific and Other-Cause Mortality (84 citations)
  • Use of Active Surveillance or Watchful Waiting for Low-Risk Prostate Cancer and Management Trends Across Risk Groups in the United States, 2010-2015. (74 citations)
  • Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies. (71 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Disease

Paul L. Nguyen mostly deals with Prostate cancer, Internal medicine, Oncology, Cancer and Radiation therapy. His Prostate cancer research includes themes of Prostate, Brachytherapy and MEDLINE. Hazard ratio, Disease, Randomized controlled trial, Clinical trial and Cohort are among the areas of Internal medicine where Paul L. Nguyen concentrates his study.

His research in Oncology intersects with topics in Meta-analysis, White, Gleason scores and Docetaxel. Paul L. Nguyen interconnects Interquartile range, Epidemiology, Retrospective cohort study and Intensive care medicine in the investigation of issues within Cancer. His study in Radiation therapy is interdisciplinary in nature, drawing from both Androgen and Cumulative incidence.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Breast Cancer Subtype Approximated by Estrogen Receptor, Progesterone Receptor, and HER-2 Is Associated With Local and Distant Recurrence After Breast-Conserving Therapy

Paul L. Nguyen;Alphonse G. Taghian;Matthew S. Katz;Andrzej Niemierko.
Journal of Clinical Oncology (2008)

907 Citations

Marital Status and Survival in Patients With Cancer

Ayal A. Aizer;Ming Hui Chen;Ellen P. McCarthy;Mallika L. Mendu.
Journal of Clinical Oncology (2013)

827 Citations

Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them

Paul L. Nguyen;Shabbir M.H. Alibhai;Shehzad Basaria;Anthony V. D’Amico.
European Urology (2015)

592 Citations

Fatty acid synthase as a potential therapeutic target in cancer

Richard Flavin;Stephane Peluso;Paul L Nguyen;Massimo Loda.
Future Oncology (2010)

580 Citations

Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving Therapy

Nils D. Arvold;Alphonse G. Taghian;Andrzej Niemierko;Rita F. Abi Raad.
Journal of Clinical Oncology (2011)

482 Citations

Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer

W. Robert Lee;James J. Dignam;Mahul B. Amin;Deborah W. Bruner.
Journal of Clinical Oncology (2016)

476 Citations

Association of Androgen Deprivation Therapy With Cardiovascular Death in Patients With Prostate Cancer: A Meta-analysis of Randomized Trials

Paul L. Nguyen;Youjin Je;Fabio A. B. Schutz;Karen E. Hoffman.
JAMA (2011)

455 Citations

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis

Jing Ma;Haojie Li;Haojie Li;Ed Giovannucci;Ed Giovannucci;Lorelei Mucci.
Lancet Oncology (2008)

452 Citations

The role of focal therapy in the management of localised prostate cancer: a systematic review

Massimo Valerio;Massimo Valerio;Hashim U Ahmed;Mark Emberton;Nathan L Lawrentschuk.
European Urology (2014)

370 Citations

Congestive Heart Failure Risk in Patients With Breast Cancer Treated With Bevacizumab

Toni K. Choueiri;Erica L. Mayer;Youjin Je;Jonathan E. Rosenberg.
Journal of Clinical Oncology (2011)

338 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Paul L. Nguyen

Alberto Briganti

Alberto Briganti

Vita-Salute San Raffaele University

Publications: 143

Pierre I. Karakiewicz

Pierre I. Karakiewicz

University of Montreal

Publications: 124

Shahrokh F. Shariat

Shahrokh F. Shariat

Medical University of Vienna

Publications: 122

Quoc-Dien Trinh

Quoc-Dien Trinh

Brigham and Women's Hospital

Publications: 121

Francesco Montorsi

Francesco Montorsi

Vita-Salute San Raffaele University

Publications: 113

Stephen J. Freedland

Stephen J. Freedland

Cedars-Sinai Medical Center

Publications: 101

Fred Saad

Fred Saad

University of Montreal

Publications: 96

Hashim U. Ahmed

Hashim U. Ahmed

Imperial College Healthcare NHS Trust

Publications: 94

Mark Emberton

Mark Emberton

University College London

Publications: 91

Markus Graefen

Markus Graefen

Universität Hamburg

Publications: 86

Matthew R. Cooperberg

Matthew R. Cooperberg

University of California, San Francisco

Publications: 81

Lorelei A. Mucci

Lorelei A. Mucci

Harvard University

Publications: 62

Adam S. Kibel

Adam S. Kibel

Brigham and Women's Hospital

Publications: 59

R. Jeffrey Karnes

R. Jeffrey Karnes

Mayo Clinic

Publications: 58

Mani Menon

Mani Menon

Henry Ford Hospital

Publications: 56

Anthony V. D'Amico

Anthony V. D'Amico

Brigham and Women's Hospital

Publications: 53

Trending Scientists

Antonio Pescapè

Antonio Pescapè

University of Naples Federico II

Olivier Pouliquen

Olivier Pouliquen

Aix-Marseille University

José L. Huertas

José L. Huertas

University of Seville

Marek E. Bialkowski

Marek E. Bialkowski

University of Queensland

Donald W. Murphy

Donald W. Murphy

Alcatel Lucent (Germany)

Michael P. Rosynek

Michael P. Rosynek

Texas A&M University

Xingshu Li

Xingshu Li

Sun Yat-sen University

Shamshad Cockcroft

Shamshad Cockcroft

University College London

Rory Johnson

Rory Johnson

University College Dublin

Lee E. Limbird

Lee E. Limbird

Fisk University

Tom J. H. Ruigrok

Tom J. H. Ruigrok

Erasmus University Rotterdam

Katharina Domschke

Katharina Domschke

University of Freiburg

Albert Mehrabian

Albert Mehrabian

University of California, Los Angeles

Daniel Aletaha

Daniel Aletaha

Medical University of Vienna

Aron H. Lichtman

Aron H. Lichtman

Virginia Commonwealth University

Francesco C. Billari

Francesco C. Billari

Bocconi University

Something went wrong. Please try again later.